Septerna (SEPN) Return on Capital Employed (2024 - 2026)
Septerna (SEPN) recorded quarterly Return on Capital Employed of 0.47% in Q1 2026, up 123.32% quarter-over-quarter from 1.99% in Q4 2025, and up 2146.0% on a YoY basis from 0.02% in Q1 2025.
Septerna (SEPN) Return on Capital Employed (2024 - 2026) Analysis & Trends
Septerna's Return on Capital Employed history runs 3 years deep, the most recent figure standing at 0.47% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 2146.0% year-over-year to 0.47%; the TTM figure through Mar 2026 stood at 0.47% (up 2146.0% YoY), while the FY2025 annual figure was 2.34%, up 2644.0% from the prior year.
- Return on Capital Employed was 0.47% for Q1 2026 at Septerna, up from 1.99% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 0.47% in Q1 2026 to a low of 26.71% in Q4 2024.
- Historically, Return on Capital Employed has averaged 15.31% across 3 years, with a median of 19.33% in 2025.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed jumped 2472 bps in 2025, then soared 2146 bps in 2026.
- A 3-year view of Return on Capital Employed shows it stood at 26.71% in 2024, then surged by 93 bps to 1.99% in 2025, then surged by 123 bps to 0.47% in 2026.
- The last three Return on Capital Employed figures came in at 0.47% (Q1 2026), 1.99% (Q4 2025), and 17.67% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 0.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.47% |
| Dec 31, 2025 | -1.99% |
| Sep 30, 2025 | -17.67% |
| Jun 30, 2025 | -24.95% |
| Mar 31, 2025 | -20.99% |
| Dec 31, 2024 | -26.71% |